Australia approves cladribine tablets

The Australian Therapeutic Goods Administration (TGA) approved Movectro cladribine tablets from Merck KGaA (Xetra:MRK) to treat relapsing-remitting multiple sclerosis (RRMS). The purine nucleoside ana...